Monte Rosa Therapeutics (GLUE) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $5.0 million.
- Monte Rosa Therapeutics' Other Non-Current Assets rose 85.57% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 85.57%. This contributed to the annual value of $4.9 million for FY2024, which is 617.9% up from last year.
- As of Q3 2025, Monte Rosa Therapeutics' Other Non-Current Assets stood at $5.0 million, which was up 85.57% from $5.0 million recorded in Q2 2025.
- Monte Rosa Therapeutics' Other Non-Current Assets' 5-year high stood at $5.3 million during Q1 2023, with a 5-year trough of $4.5 million in Q3 2023.
- In the last 3 years, Monte Rosa Therapeutics' Other Non-Current Assets had a median value of $4.9 million in 2024 and averaged $4.8 million.
- Examining YoY changes over the last 5 years, Monte Rosa Therapeutics' Other Non-Current Assets showed a top increase of 853.6% in 2024 and a maximum decrease of 791.52% in 2024.
- Monte Rosa Therapeutics' Other Non-Current Assets (Quarter) stood at $4.6 million in 2023, then grew by 6.18% to $4.9 million in 2024, then grew by 1.79% to $5.0 million in 2025.
- Its Other Non-Current Assets was $5.0 million in Q3 2025, compared to $5.0 million in Q2 2025 and $4.9 million in Q1 2025.